Hawthorne Health is revolutionizing clinical research by making it local and accessible, right in the heart of communities. We break down barriers by bringing trials directly to patients—whether in their homes or at one of over 1,000 convenient in-community locations. Powered by the largest network of GCP-trained clinicians and our cutting-edge Visit Delivery Platform, we ensure fast, efficient, and seamless protocol visits. By including those traditionally left out, we're not just conducting research—we're accelerating the future of healthcare. For more information, go to: https://hawthornehealth.com/

AlphaLife Sciences, a globally leading AI-enabled integrated clinical research platform enables Generative AI-Co-piloted authoring and document generation across drug development such as protocol design, safety narratives and clinical study reports. We are proud partners with Microsoft's Pegasus Program, Google for Startups, Johnson & Johnson Innovation JLABS and NVIDIA. For more information, go to https://www.alphalifesci.com/

Bryllan LLC is a fill finish CMO focused on supporting the product life cycle of complex drug and device combinations. Bryllans core competency is to solve complex filling problems. Enhanced formulation science combined with device innovation provides a platform for the development of more complex drug delivery and Bryllan is uniquely positioned to support this need with flexible and scalable fill finish capacity. Bryllan currently offers development and clinical supply in syringes, cartridges and IV Bags and is actively pursuing commercial scale fill-finish capacity for liquid-liquid and powder-liquid syringe and cartridge formats to provide significant commercial volumes. For more information, visit www.Bryllan.com

Argonaut Manufacturing Services is a leading contract development and manufacturing organization (CDMO) dedicated to supporting biopharmaceutical and combination product innovators with high quality GMP manufacturing services in the areas of formulation, aseptic fill/finish, kitting, device assembly, and distribution. Argonaut’s Aseptic Drug Product Fill/Finish facility is designed for clients in pre-clinical through commercial phase. Find out more by visiting https://www.argonautms.com

Rommelag Engineering’s BLOW-FILL-SEAL ADVANCED ASEPTIC LIQUID PACKAGING is the world leader in the manufacture of the filling machines. Achieve unparalleled flexibility, heightened performance, and uncompromising safety—all housed in the industry's most compact design. Packaging solutions with its bottelpack® Blow/Fill/Seal technology in plastic containers in a wide range of sizes and shapes that are formed, filled, and sealed within a single step, avoiding the need for pre-formed containers. We offer are machine construction and sales as well as CDMO services. For more information, visit https://www.rommelag.com

InSilicoTrials aims to become the leading problem solver in drug development by leveraging computational modeling and simulation (in silico) techniques. Using AI and advanced predictive technologies, our cloud based platform supports emerging biotech companies, pharma and CROs by generating robust digital evidence that enhances funding prospects and clinical outcomes. Our in silico methods reduce R&D time and costs, offering:

• Virtual Patient and AI-enhanced trial accuracy.
• Cloud-based simulations for comprehensive virtual assessments.
• Regulatory-compliant data to support clinical programs.

Our commitment has not gone unnoticed: we are proud recipients of the AI Startup of the Year Award by Startup Grind Global 2024, and of the Innovation Radar Prize 2023 by the European Commission in the AI & Smart Devices category. For more information, go to https://insilicotrials.com/

Vesselon develops drug co-formulations using an FDA-approved, biophysically activated lipid microsphere. These co-formulations safely make targeted tissues more receptive to therapeutic drugs, producing unprecedented levels of efficacy. Our third-generation oncolytic adenovirus has been shown to produce far greater CD8+ infiltrates as well as tumor necrosis with our IV microsphere delivery system than intratumoral injections. To learn more please visit www.vesselon.com.

United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For more information, go to www.ubc.com.

Modular Medical is a medical technology company focused on improving insulin delivery systems. Its flagship product, the MODD1, is a user-friendly insulin patch pump designed to be more accessible, affordable, and simpler for both patients and healthcare providers. FDA-cleared for use with insulin-dependent Type 1 and Type 2 diabetics, MODD1 aims to enhance the daily management of diabetes with an easier-to-prescribe and more cost-effective solution. For more information, please visit https://www.modular-medical.com/

Anodyne is a Boston-based, clinical-stage biotech company developing a pipeline of next-generation obesity and cardiometabolic therapies powered by its proprietary HeroPatch™ platform. The HeroPatch enables the transdermal delivery of multi- milligram doses of biologics, with improved pharmacokinetic profiles and room temperature stability. Our pipeline includes: ANN-101 (GLP-1RA patch for obesity), ANN-102 (apelin RA patch for muscle preservation), and ANN-103 (GLP-1RA + APJ-RA combination patch). Anodyne is looking for additional pharmaceutical partnership to expand the reach of its platform. To learn more please visit theheropatch.com

TOTAL Diversity Clinical Trial Management is a full-service Contract Research Organization with an integrated focus on support services highlighting diversity and inclusion in clinical trials. Service offerings directed at diversity include consulting, training programs, patient recruitment, and retention services. In addition, diversity action planning required by the FDA is customized per client needs. For more information, go to https://totaldiversity.com/.